Rémy Cointreau (RMC) H2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
H2 24/25 earnings summary
21 Nov, 2025Executive summary
Navigated a challenging year marked by macroeconomic volatility, geopolitical tensions, and shifting consumer behavior, with a focus on long-term brand value and sustainability.
CEO transition planned, with Franck Marilly set to succeed Eric Vallat in June 2025, bringing expertise in high-end brands and transformation.
Maintained or increased global market share for key brands, notably Rémy Martin and Cointreau.
Cost efficiencies and sustainability initiatives delivered, including significant reductions in emissions and water use.
Cost-cutting exceeded targets, achieving €85m savings vs €50m expected.
Financial highlights
Group sales reached €984.6 million, down 18% organically year-over-year; reported sales down 17.5%.
Current operating profit (COP) was €217 million, down 28.7% year-over-year and 30.5% organically, with a COP margin of 21.6–22.0%.
Net profit group share was €121.2 million, down 34.4%, with EPS at €2.36, down 35.3%.
Free cash flow increased to €19.2 million, up from €13.8 million prior year.
Net debt/EBITDA ratio increased to 2.4x at March 2025.
Outlook and guidance
2025-26 guidance: return to mid-single-digit organic sales growth, led by a technical rebound in the U.S.
COP guidance: high single- to low double-digit organic growth excluding tariffs; mid- to high teens decline if tariffs are imposed.
Potential tariffs in China and US could have up to €65m net impact on COP after mitigation.
Withdrew 2029-2030 targets due to macro/geopolitical uncertainty and CEO transition.
Latest events from Rémy Cointreau
- Q3 organic sales up 2.8% as U.S. and EMEA gains offset APAC and China weakness.RMC
Q3 2026 TU3 Feb 2026 - Q1 sales dropped 15.6% organically, with gradual recovery and cost controls underway.RMC
Q1 24/25 TU3 Feb 2026 - Sales and profit dropped, but cost savings and recovery with high single-digit growth are targeted.RMC
H2 23/241 Feb 2026 - H1 sales dropped 15.9% organically, triggering revised guidance and a major cost-cutting plan.RMC
H1 24/25 TU18 Jan 2026 - Sales and profit dropped, but margins held up due to aggressive cost controls.RMC
H1 24/2512 Jan 2026 - Q3 sales fell 21.5% organically; full-year decline near 18% with margin guidance held.RMC
Q3 24/25 TU9 Jan 2026 - Sales fell 18% organically; margin guidance held, cost savings and tariff risks remain.RMC
Q4 24/25 TU29 Nov 2025 - Sales and profit declined, but transformation and investment in recovery continue.RMC
H1 25/2627 Nov 2025 - H1 sales dropped 4.2% organically, prompting a guidance cut amid China and currency headwinds.RMC
Q2 25/26 TU31 Oct 2025